8-K · AMGN
Amgen files an 8-K on quarterly results
Amgen filed a Form 8-K on Nov 3, 2026 at 4:05 PM ET under Item 2.02 (Results of Operations and Financial Condition).
Under Item 2.02, the filing says: “In its press release the Company included certain non-U.S. Generally Accepted Accounting Principles (GAAP) financial measures as defined in Regulation G promulgated by the Securities and Exchange Commission.”
The filing attaches a press release as Exhibit 99.1 (EARNINGS RELEASE).
Source
- 8-K filed Nov 3, 2026 (document)
- Filing index on SEC EDGAR (all documents and exhibits)
Read the earnings recap: what the press release reported, with year-ago figures →
Amgen company file → · More Amgen filings
Disclosures
- Editor holdings in AMGN
- The editor holds no position in Amgen (AMGN). As of Nov 11, 2026.
- Last updated
- Nov 3, 2026
A summary of a public filing for general education, the same for every reader. Not a recommendation to buy, sell or hold AMGN.